As obesity and insulin resistance are commonly found in patients with endometrial cancer [8,9], a recent report suggests a role of increased non-genomic GPER signaling in endometrial cancer cells through TET1 upregulation in tumor microenvironment (Figure 6e), through a yet, to-be defined mechanism [217]. This evidence concerns the gene GPER1 and endometrial cancer.